Demonstration of epstein-barr virus-associated nuclear antigen in nasopharyngeal carcinoma cells from fresh biopsies
✍ Scribed by D. P. Huang; J. H. C. Ho; W. Henle; G. Henle
- Publisher
- John Wiley and Sons
- Year
- 1974
- Tongue
- French
- Weight
- 862 KB
- Volume
- 14
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Fresh nasopharyngeal carcinoma (NPC) biopsies were treated in several ways to yield satisfactory cell preparations for detection of Epstein‐Barr virus (EBV)‐associated nuclear antigen (EBNA) by anti‐complement immunofluorescence tests. If the cells were well dispersed (trypsinization or extensive mechanical dispersal) few or none of them were EBNA‐positive. In contrast, if the biopsy preparations contained small to moderately sized tissue fragments (touch preparations or limited mechanical dispersal), nuclear staining was detected in nearly every cell at the margin of the fragments or in cell sheets protruding from them. The stained cells corresponded to the carcinoma cells when compared to histologically stained replicate cell preparations. Nuclear staining was obtaining with anti‐EBNA positive sera [healthy donors, NPC patients, convalescents from infectious mononucleosis (IM)], shown to be free of antibodies to other nuclear antigens, but not with anti‐EBNA negative sera (healthy donors or patients in the early acute phase of IM). These results confirm and extend previous reports that the carcinoma cells harbor EBV genomes. The implications of these findings are discussed.
📜 SIMILAR VOLUMES
A new monoclonal antibody bas been used to examine immunohistochemically the expression of the Epstein-Barr virus (EBV)encoded nuclear antigen (EBNA) 1 in virus-associated epithelial lesions. EBNAl was detected in the tumour cell nuclei of 10113 undifferentiated nasopharyngeal carcinomas and of 1011
Nasopharyngeal carcinoma (NPC) is consistently associated with Epstein-Barr virus (EBV) and mostly classified as poorly differentiated squamous cell carcinoma or undifferentiated carcinoma with early metastasis and a rapidly progressive clinical. course. The EBV-encoded latent proteins, Epstein-Barr
In a previous study of Epstein-Barr virus (EBV) strains in North African nasopharyngeal carcinoma (NPC) biopsies, we have found that the viral strain present was of A/F/WЈ-IЈ/ Xho1kept/H1-H2 type, while the strain associated with Chinese NPC was the A/''f''/WЈIЈ/Xho1lost/H type. Using the restrictio
## Abstract The Epstein‐Barr virus nuclear antigen I (EBNA I) is the only latent EBV antigen consistently expressed in malignant tissues of the nasopharynx. A 20‐amino‐acid synthetic peptide, p107 contains a major epitope of EBNA I. We tested sera from 210 patients with nasopharyngeal carcinoma (NP
IgG and IgA antibodies to Epstein-Barr virus (EBV) membrane antigen (MA) were detected in sera from 96 NPC patients and normal individuals by the indirect immunofluorescence test. For MA/IgG antibody, 100% of NPC patients were positive with a GMT of 1:439.7 and 97.9% of normal individuals were posit